PRESS RELEASE published on 09/18/2025 at 07:00, 9 months 6 days ago FDA minutes confirm positive outcome of meeting on 9. September 2025 – Corticorelin on track for Phase 3 Curatis Holding AG receives positive outcome confirmation from FDA meeting regarding corticorelin's Phase 3 development plan for patients with PTBE secondary to solid tumor brain metastases Phase 3 Curatis Holding AG FDA Meeting Corticorelin PTBE
BRIEF published on 09/15/2025 at 07:05, 9 months 9 days ago Curatis annonce une croissance de son chiffre d'affaires et fait progresser le développement du C-PTBE-01 Partenariat Croissance Des Revenus Curatis Holding AG Réunion De La FDA Développement Du C-PTBE-01
BRIEF published on 09/15/2025 at 07:05, 9 months 9 days ago Curatis Reports Revenue Growth and Advances C-PTBE-01 Development Revenue Growth Partnership Curatis Holding AG FDA Meeting C-PTBE-01 Development
PRESS RELEASE published on 09/15/2025 at 07:00, 9 months 9 days ago Curatis: Double-digit growth in core business and development milestone achieved for C-PTBE-01 Curatis Holding AG reports double-digit revenue growth in H1 2025, signing a significant partnership with Phoenix Labs for C-PTBE-01. Financials show a loss due to increased development expenses for corticorelin Revenue Growth Partnership Financials Curatis Holding AG C-PTBE-01
BRIEF published on 09/05/2025 at 07:05, 9 months 19 days ago Curatis va augmenter ses revenus grâce à un partenariat avec Phoenix Labs Suisse Accord De Distribution Croissance Des Revenus Curatis Laboratoires Phoenix
BRIEF published on 09/05/2025 at 07:05, 9 months 19 days ago Curatis to Boost Revenue with Phoenix Labs Partnership Revenue Growth Distribution Agreement Switzerland Curatis Phoenix Labs
PRESS RELEASE published on 09/05/2025 at 07:00, 9 months 19 days ago Curatis expands distribution business with Phoenix Labs with up to CHF 5m additional annual revenues Curatis Holding AG announces new distribution contract with Phoenix Labs (Ireland) for four products in Switzerland, expecting up to CHF 5 million additional annual revenues from October 2025 Revenue Growth Switzerland Curatis Holding AG Phoenix Labs Distribution Contract
BRIEF published on 07/31/2025 at 06:05, 10 months 24 days ago FDA Schedules Type B Meeting for Curatis' Phase 3 Corticorelin Trial Phase 3 Trial Curatis Holding AG FDA Meeting Corticorelin PTBE Treatment
BRIEF published on 07/31/2025 at 06:05, 10 months 24 days ago La FDA organise une réunion de type B pour l'essai de phase 3 de Curatis sur la corticoréline Essai De Phase 3 Curatis Holding AG Réunion De La FDA Corticoréline Traitement PTBE
PRESS RELEASE published on 07/31/2025 at 06:00, 10 months 24 days ago FDA Confirms Type B Meeting on Corticorelin Pivotal Phase 3 Study FDA confirms Type B meeting with Curatis Holding AG to review Phase 3 plan for investigational biologic corticorelin, targeting Peritumoral Brain Edema. Development aims to reduce steroid use in patients FDA Phase 3 Study Curatis Holding AG Corticorelin Type B Meeting
Published on 06/24/2026 at 03:15, 6 hours 47 minutes ago Noram Lithium Adopts Semi-Annual Financial Reporting
Published on 06/24/2026 at 00:00, 10 hours 2 minutes ago Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
Published on 06/23/2026 at 23:45, 10 hours 17 minutes ago Prospect Ridge Aligns with the Market Mindset for Exclusive Live Investor Interview Discussing Game-changing 2026 Drill Programs
Published on 06/23/2026 at 23:20, 10 hours 42 minutes ago BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/23/2026 at 23:15, 10 hours 47 minutes ago EV Nickel Signs LOI Forming High-Grade Nickel Joint Venture for Shaw Dome Projects
Published on 06/24/2026 at 09:46, 16 minutes ago Elring extends Aftermarket portfolio to include solutions for commercial vehicles from Asian OEMs
Published on 06/24/2026 at 09:37, 25 minutes ago KNDS ANNOUNCES INTENTION TO PROCEED WITH AN IPO TO SUPPORT ITS LONG-TERM GROWTH STRATEGY
Published on 06/24/2026 at 09:34, 27 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 06/24/2026 at 09:30, 32 minutes ago CP HOPENING - Le 1er Baromètre “Libéralités - Grande Transmission”
Published on 06/23/2026 at 19:47, 14 hours 14 minutes ago GROUPE SFPI: reorganisation de la Direction Générale
Published on 06/23/2026 at 19:47, 14 hours 14 minutes ago GROUPE SFPI: General management reorganisation
Published on 06/23/2026 at 19:10, 14 hours 52 minutes ago GUILLEMOT CORPORATION > EVOLUTION DE LA GOUVERNANCE A COMPTER DU 23 JUIN 2026
Published on 06/23/2026 at 19:10, 14 hours 52 minutes ago GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026